| Ira Cohen, MD | |
|
111 Michigan Ave Nw, Washington, DC 20010-2978 | |
| (202) 884-2025 | |
| Not Available |
| Full Name | Ira Cohen |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology - Pediatric Anesthesiology |
| Location | 111 Michigan Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437235694 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP3000X | Anesthesiology - Pediatric Anesthesiology | MD18182 (District Of Columbia) | Primary |
| Entity Name | Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912939703 PECOS PAC ID: 0244143170 Enrollment ID: O20031107000130 |
News Archive
When cells are confronted with an invading virus or bacteria or exposed to an irritating chemical, they protect themselves by going off their DNA recipe and inserting the wrong amino acid into new proteins to defend them against damage, scientists have discovered.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten registered public offering of 18,310,000 shares of its common stock at a public offering price of $2.80 per share. All of the shares are being sold by Idenix.
University of Kentucky researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means.
Depending on which hospital you go to for your low-risk surgical procedure, you may be 2.4 times more or less likely to be sent for unnecessary blood tests. This is among the findings of a study conducted by researchers from the Institute of Clinical Evaluative Sciences and the Women's College Hospital Institute for Health Systems Solutions and Virtual Care.
› Verified 1 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1710106414 PECOS PAC ID: 4981745098 Enrollment ID: O20200323000179 |
News Archive
When cells are confronted with an invading virus or bacteria or exposed to an irritating chemical, they protect themselves by going off their DNA recipe and inserting the wrong amino acid into new proteins to defend them against damage, scientists have discovered.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten registered public offering of 18,310,000 shares of its common stock at a public offering price of $2.80 per share. All of the shares are being sold by Idenix.
University of Kentucky researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means.
Depending on which hospital you go to for your low-risk surgical procedure, you may be 2.4 times more or less likely to be sent for unnecessary blood tests. This is among the findings of a study conducted by researchers from the Institute of Clinical Evaluative Sciences and the Women's College Hospital Institute for Health Systems Solutions and Virtual Care.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ira Cohen, MD 111 Michigan Ave Nw, Washington, DC 20010-2978 Ph: (202) 884-2025 | Ira Cohen, MD 111 Michigan Ave Nw, Washington, DC 20010-2978 Ph: (202) 884-2025 |
News Archive
When cells are confronted with an invading virus or bacteria or exposed to an irritating chemical, they protect themselves by going off their DNA recipe and inserting the wrong amino acid into new proteins to defend them against damage, scientists have discovered.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten registered public offering of 18,310,000 shares of its common stock at a public offering price of $2.80 per share. All of the shares are being sold by Idenix.
University of Kentucky researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means.
Depending on which hospital you go to for your low-risk surgical procedure, you may be 2.4 times more or less likely to be sent for unnecessary blood tests. This is among the findings of a study conducted by researchers from the Institute of Clinical Evaluative Sciences and the Women's College Hospital Institute for Health Systems Solutions and Virtual Care.
› Verified 1 days ago
Dr. Fay Horng, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7504 | |
Dr. Matthew Mueller, DO, MPH Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Dr. Shane Zamani, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 900 23rd St Nw, Washington, DC 20037 Phone: 202-715-4750 | |
Dr. Thomas Edward Borsari, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 50 Irving St Nw, Dept Of Anesthesiology, Washington, DC 20422 Phone: 202-745-8000 | |
Alexis Lambros, CAA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-2025 | |
Susan Verghese, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-884-2025 | |
Joan Threlfall, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Washington, DC 20007 Phone: 202-444-8640 |